Chronic Achilles tendinosis affects both physically active and inactive individuals accounting for 30 to 50% of all sports injuries and 50% of occupation-related disorders in the United States. The study will include 28 participants with chronic Achilles tendinosis. Study participants will receive ultrasound-guided injections of either RCT-01 or placebo (on a 3:1 treatment-to-placebo ratio) directly into areas of injury within the Achilles tendon. Participants’ overall health and tendinosis will be monitored over a six month period while they undergo post-treatment physiotherapy to help facilitate recovery from their Achilles tendinosis.
The Ottawa Hospital leads first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis.
Surgical breakthrough - paralysed man walks again after cell transplantation treatment developed by scientists at UCL and applied by surgeons at Wroclaw University Hospital, Poland.
Surgeons implanted a retinal pigment epithelium which was reprogrammed from patient's skin.
Pilot Imperial College study has successfully used a new and safe technique to aid recovery from stroke by delivering a patient's own stem cells.
The NIH and Mesoblast trial aims to analyze the use of single intracardiac injections of allogeneic MPCs in reducing need for LVAD support and recurrent hospitalizations.